Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Acacia Research
ACTG
$448M
| $856K | ﹤0.01% |
125,937
-218,200
| -63% | -$1.34M |
|
2927
Covenant Logistics
CVLG
$879M
| $851K | ﹤0.01% |
61,488
-372
| -0.6% | -$4.16K |
|
2928
AXT Inc
AXTI
$5.07B
| $847K | ﹤0.01% |
101,583
| – | – |
|
2929
Blue Bird Corp
BLBD
$2.05B
| $847K | ﹤0.01% |
40,577
+1,172
| +3% | +$26K |
|
2930
Kiniksa Pharmaceuticals
KNSA
$6.08B
| $845K | ﹤0.01% |
74,170
+3,874
| +6% | +$50.5K |
|
2931
ClearPoint Neuro
CLPT
$470M
| $841K | ﹤0.01% |
47,355
+1,139
| +2% | +$21.4K |
|
|
SIEN
2932
DELISTED
Sientra, Inc.
SIEN
| $839K | ﹤0.01% |
14,632
+338
| +2% | +$23.1K |
|
2933
CytomX Therapeutics
CTMX
$730M
| $837K | ﹤0.01% |
164,258
-345,671
| -68% | -$1.85M |
|
2934
Capital City Bank Group
CCBG
$898M
| $836K | ﹤0.01% |
33,755
| – | – |
|
2935
Cytosorbents Corp
CTSO
$22.9M
| $836K | ﹤0.01% |
102,878
-518
| -0.5% | -$4.21K |
|
|
CNBKA
2936
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $834K | ﹤0.01% |
7,233
+221
| +3% | +$25.3K |
|
2937
Hooker Furnishings Corp
HOFT
$159M
| $833K | ﹤0.01% |
30,827
+743
| +2% | +$23.8K |
|
2938
Primis Financial Corp
FRST
$413M
| $828K | ﹤0.01% |
57,233
-662
| -1% | -$9.9K |
|
2939
Donegal Group Class A
DGICA
$696M
| $827K | ﹤0.01% |
57,057
-56,556
| -50% | -$851K |
|
2940
MeiraGTx Holdings
MGTX
$1.17B
| $827K | ﹤0.01% |
62,693
-419
| -0.7% | -$5.74K |
|
|
AMPE
2941
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $825K | ﹤0.01% |
1,655
+66
| +4% | +$30.6K |
|
2942
InnovAge Holding
INNV
$1.44B
| $824K | ﹤0.01% |
124,548
+987
| +0.8% | +$15.3K |
|
2943
iShares Russell 1000 Growth ETF
IWF
$129B
| $823K | ﹤0.01% |
12,000
+400
| +3% | +$28.3K |
|
|
MGP
2944
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $823K | ﹤0.01% |
21,500
-363
| -2% | -$14.2K |
|
|
CTO
2945
CTO Realty Growth
CTO
$822M
| $822K | ﹤0.01% |
45,849
+1,389
| +3% | +$25.3K |
|
2946
Artesian Resources
ARTNA
$369M
| $821K | ﹤0.01% |
21,491
| – | – |
|
|
ESPR
2947
DELISTED
Esperion Therapeutics
ESPR
| $821K | ﹤0.01% |
68,083
-122,414
| -64% | -$1.78M |
|
2948
Lakeland Industries
LAKE
$117M
| $821K | ﹤0.01% |
39,074
-11,912
| -23% | -$278K |
|
2949
Rocky Brands
RCKY
$355M
| $815K | ﹤0.01% |
17,104
-9
| -0.1% | -$448 |
|
2950
Kodak
KODK
$978M
| $812K | ﹤0.01% |
119,204
-90
| -0.1% | -$657 |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.